Suicidality risk of newer antiseizure medications: a meta-analysis - Klein P, Devinsky O, French J, Harden C, Krauss GL, McCarter R, Sperling MR.

IMPORTANCE: Most antiseizure medications (ASMs) carry a US Food and Drug Administration-mandated class label warning of increased suicidality risk, based on a meta-analysis comparing suicidality between individuals treated with medications vs placebo in ra...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news